Fidelity Select Portfolios · net assets $6.2B · 135 holdings as of February 28, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 94.4% · STIV: 3.9% · EP: 1.5% · DBT: 0.1%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $36.3M | $31.6M | $19.6M |
| Reinvestment | $394M | $0 | $0 |
| Redemptions | $109M | $119M | $84.4M |
| Net realized gain (non-derivative) | $136M | $249M | $153M |
| Net unrealized appreciation (non-derivative) | $-333M | $-242M | $-169M |
The three months of the reporting period, as filed; month 3 ends February 28, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Eli Lilly And Co EC | $429M | 6.93% |
| Danaher Corp EC | $396M | 6.39% |
| Boston Scientific Corp EC | $373M | 6.01% |
| Johnson And Johnson EC | $348M | 5.61% |
| Abbvie Inc EC | $265M | 4.27% |
| Fidelity Revere Street Trust STIV | $225M | 3.62% |
| Ascendis Pharma A/s EC | $167M | 2.70% |
| Ucb Sa EC | $161M | 2.60% |
| Gilead Sciences Inc EC | $161M | 2.60% |
| Merck And Co Inc EC | $158M | 2.56% |
| Argenx Se EC | $153M | 2.48% |
| Edwards Lifesciences Corp EC | $138M | 2.23% |
| Cvs Health Corp EC | $120M | 1.93% |
| Alnylam Pharmaceuticals Inc EC | $113M | 1.83% |
| Thermo Fisher Scientific Inc EC | $110M | 1.78% |
| Cogent Biosciences Inc EC | $99.5M | 1.60% |
| Mckesson Corp EC | $93.8M | 1.51% |
| Brightspring Health Services Inc EC | $86.2M | 1.39% |
| Moderna Inc EC | $85.7M | 1.38% |
| Insmed Inc EC | $83.6M | 1.35% |
| Viridian Therapeutics Inc EC | $82.8M | 1.34% |
| Unitedhealth Group Inc EC | $82.1M | 1.33% |
| Nuvalent Inc EC | $77.5M | 1.25% |
| Roche Holding Ag EC | $76.1M | 1.23% |
| Cencora Inc EC | $74.4M | 1.20% |
| Royalty Pharma PLC EC | $69.3M | 1.12% |
| Insulet Corp EC | $66.6M | 1.07% |
| Waystar Holding Corp EC | $64.1M | 1.03% |
| Vaxcyte Inc EC | $61.7M | 1.00% |
| Caris Life Sciences Inc EC | $61.4M | 0.99% |
| Stryker Corp EC | $58.1M | 0.94% |
| Xenon Pharmaceuticals Inc EC | $55.8M | 0.90% |
| Repligen Corp EC | $55.1M | 0.89% |
| Veeva Sys Inc EC | $54.6M | 0.88% |
| Privia Health Group Inc EC | $54.2M | 0.87% |
| Praxis Precision Medicines Inc. EC | $53.9M | 0.87% |
| Legend Biotech Corp EC | $53.2M | 0.86% |
| Crinetics Pharmaceuticals Inc EC | $52.6M | 0.85% |
| Intuitive Surgical Inc EC | $50.4M | 0.81% |
| Medline Inc EC | $47.5M | 0.77% |
| Cg Oncology Inc EC | $47M | 0.76% |
| Centessa Pharmaceuticals PLC EC | $44.3M | 0.72% |
| Disc Medicine Inc EC | $43.3M | 0.70% |
| Spyre Therapeutics Inc EC | $40.4M | 0.65% |
| Structure Therapeutics Inc EC | $39M | 0.63% |
| Alignment Healthcare Inc EC | $38.4M | 0.62% |
| Enliven Therapeutics Inc EC | $38M | 0.61% |
| Veracyte Inc EC | $37.7M | 0.61% |
| Cytokinetics Inc EC | $37.3M | 0.60% |
| Roivant Sciences Ltd EC | $37M | 0.60% |
| 10x Genomics Inc EC | $36.9M | 0.60% |
| Kiniksa Pharmaceuticals International PLC EC | $35.6M | 0.57% |
| Oruka Therapeutics Inc EC | $34.6M | 0.56% |
| Olema Pharmaceuticals Inc EC | $32.7M | 0.53% |
| Lifestance Health Group Inc EC | $32.6M | 0.53% |
| Biontech Se EC | $30.9M | 0.50% |
| Mineralys Therapeutics Inc EC | $29.3M | 0.47% |
| Cigna Group (the) EC | $29M | 0.47% |
| Beone Medicines Ltd EC | $28.5M | 0.46% |
| Zenas Biopharma Inc EC | $28.5M | 0.46% |
Showing top 60 of 135 holdings.
Loading...
